| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ... Arthritis & rheumatism 62 (9), 2569-2581, 2010 | 15472 | 2010 |
| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis DO Clegg, DJ Reda, CL Harris, MA Klein, JR O'Dell, MM Hooper, ... New England Journal of Medicine 354 (8), 795-808, 2006 | 2159 | 2006 |
| Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0 M Boers, JR Kirwan, G Wells, D Beaton, L Gossec, MA d'Agostino, ... Journal of clinical epidemiology 67 (7), 745-753, 2014 | 858 | 2014 |
| Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases RR Edwards, CO Bingham III, J Bathon, JA Haythornthwaite Arthritis Care & Research: Official Journal of the American College of …, 2006 | 721 | 2006 |
| Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial CO Bingham III, RJ Looney, A Deodhar, N Halsey, M Greenwald, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 506 | 2010 |
| Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment … CO Bingham III, JC Buckland‐Wright, P Garnero, SB Cohen, M Dougados, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 462 | 2006 |
| Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients RF Van Vollenhoven, P Emery, CO Bingham, EC Keystone, ... Annals of the rheumatic diseases 72 (9), 1496-1502, 2013 | 432 | 2013 |
| The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial AD Sawitzke, H Shi, MF Finco, DD Dunlop, CO Bingham III, CL Harris, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 416 | 2008 |
| Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT AD Sawitzke, H Shi, MF Finco, DD Dunlop, CL Harris, NG Singer, ... Annals of the rheumatic diseases 69 (8), 1459-1464, 2010 | 402 | 2010 |
| Rheumatic and musculoskeletal immune‐related adverse events due to immune checkpoint inhibitors: a systematic review of the literature LC Cappelli, AK Gutierrez, CO Bingham III, AA Shah Arthritis care & research 69 (11), 1751-1763, 2017 | 399 | 2017 |
| Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab LC Cappelli, AK Gutierrez, AN Baer, J Albayda, RL Manno, U Haque, ... Annals of the rheumatic diseases 76 (1), 43-50, 2017 | 393 | 2017 |
| Core outcome measures for clinical research in acute respiratory failure survivors. An international modified Delphi consensus study DM Needham, KA Sepulveda, VD Dinglas, CM Chessare, LA Friedman, ... American journal of respiratory and critical care medicine 196 (9), 1122-1130, 2017 | 392 | 2017 |
| The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report T Neogi, D Aletaha, AJ Silman, RL Naden, DT Felson, R Aggarwal, ... Arthritis & Rheumatism 62 (9), 2582-2591, 2010 | 369 | 2010 |
| Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials RF Van Vollenhoven, P Emery, CO Bingham, EC Keystone, ... The Journal of rheumatology 37 (3), 558-567, 2010 | 328 | 2010 |
| The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study NA Shadick, MH Liang, AJ Partridge, C Bingham, E Wright, AH Fossel, ... Journal of allergy and clinical immunology 104 (1), 123-127, 1999 | 297 | 1999 |
| The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. CO Bingham The Journal of Rheumatology Supplement 65, 3-9, 2002 | 260 | 2002 |
| The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis KL Winthrop, J Silverfield, A Racewicz, J Neal, EB Lee, P Hrycaj, ... Annals of the rheumatic diseases 75 (4), 687-695, 2016 | 235 | 2016 |
| Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells H Fujishima, RO Sanchez Mejia, CO Bingham III, BK Lam, A Sapirstein, ... Proceedings of the National Academy of Sciences 96 (9), 4803-4807, 1999 | 234 | 1999 |
| Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions CO Bingham III, M Moni Current opinion in rheumatology 25 (3), 345-353, 2013 | 232 | 2013 |
| Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis SJ Bartlett, AM Orbai, T Duncan, E DeLeon, V Ruffing, K Clegg-Smith, ... PloS one 10 (9), e0138543, 2015 | 222 | 2015 |